Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma

J Am Acad Dermatol. 2014 Nov;71(5):e205-6. doi: 10.1016/j.jaad.2014.03.043. Epub 2014 Oct 15.

Authors

Aaron R Mangold¹, Alan Bryce², Aleksandar Sekulic³

Affiliations

¹ Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
² Department of Internal Medicine, Division of Oncology, Mayo Clinic, Scottsdale, Arizona.
³ Department of Dermatology, Mayo Clinic, Scottsdale, Arizona. Electronic address: [email protected].

PMID: 25437992
DOI: 10.1016/j.jaad.2014.03.043

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents / adverse effects*
Disease Progression
Fatal Outcome
Female
Gingival Hyperplasia / chemically induced*
Humans
Indoles / adverse effects*
Melanoma / drug therapy*
Melanoma / secondary
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Sulfonamides / adverse effects*
Vemurafenib

Substances

Antineoplastic Agents
Indoles
Sulfonamides
Vemurafenib